Drug Shortage Report for MYLAN-NIFEDIPINE EXTENDED RELEASE

Last updated on 2020-01-09 History
Report ID 33010
Drug Identification Number 02321149
Brand name MYLAN-NIFEDIPINE EXTENDED RELEASE
Common or Proper name NIFEDIPINE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) NIFEDIPINE
Strength(s) 60MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100 BT
ATC code C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-10-15
Actual start date 2018-10-15
Estimated end date 2020-01-05
Actual end date 2020-01-08
Shortage status Resolved
Updated date 2020-01-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v35 2018-04-27 French Compare
v34 2018-04-27 English Compare
v33 2018-04-24 French Compare
v32 2018-04-24 English Compare
v31 2018-04-20 English Compare
v30 2018-04-18 French Compare
v29 2018-04-18 English Compare
v28 2018-04-18 English Compare
v27 2018-04-16 French Compare
v26 2018-04-16 English Compare
v25 2018-04-13 French Compare
v24 2018-04-13 English Compare
v23 2018-04-13 English Compare
v22 2018-04-11 French Compare
v21 2018-04-11 English Compare
v20 2018-03-26 French Compare
v19 2018-03-26 English Compare
v18 2018-03-07 French Compare
v17 2018-03-07 English Compare
v16 2018-02-27 French Compare

Showing 81 to 100 of 115